25.11.2011

25.11.2011 22-25.11.2011 in Moscow, "Crocus Expo", there was held the 13th International Specialized Exhibition "Pharmtech, Technologies of Pharmaceutical Industry"

Возврат к списку

News

24.05.2022
Сообщение о дате, до которой будут приниматься предложения о внесении вопросов в повестку дня и о выдвижении кандидатов для избрания в выборные органы на годовом собрании акционеров ОАО «Фармацевтическая фабрика Санкт-Петербурга»

28.09.2015
GSK receives positive CHMP opinion in Europe for novel anti-IL5 biological Nucala (mepolizumab) for the treatment of patients with severe refractory eosinophilic asthma.

09.09.2015
GlaxoSmithKline's inhaled medicine Breo failed to prolong life in patients with chronic respiratory disease in a high-stakes clinical trial of 16,500 people, torpedoing hopes of a sales boost for the drug.

13.08.2015
GlaxoSmithKline is banking on a major clinical trial to revive its flagging respiratory medicine business, with billions of dollars of sales riding on a positive result.

13.07.2015
The approximate 1 in 10 asthma patients who have severe disease do not respond to mainstay corticosteroid treatment, even in high doses. That could be because the immune response that occurs in the airways of severe asthma patients markedly differs from what is seen in mild-moderate disease, a team of researchers recently posited.

02.07.2015
The U.S. Food and Drug Administration today approved the first drug for cystic fibrosis directed at treating the cause of the disease in people who have two copies of a specific mutation.

25.09.2014
Anoro Ellipta, a novel inhaler containing a long-acting muscarinic receptor antagonist and a selective long-acting beta-2 adrenergic receptor agonist, may find a limited place in therapy for a small group of patients.